Associations between classical Alzheimer's Disease biomarkers and key proteins defining potential pathophysiological mechanisms – A multi‐analyte proteomic analysis

Abstract Background Plasma biomarkers like amyloid‐beta Aβ42/Aβ40, p ‐tau isoforms, and NfL are promising for assessing AD risk and pathology. Emerging platforms such as Nucleic Acid‐Linked Immuno‐Sandwich Assay (NULISA) enable precise detection of low‐abundance proteins, offering insights into AD mechanisms. We examined associations between Alamar's NULISA proteins related to AD (amyloid, tau, neurodegeneration, and inflammation [ATN & I]) and Alamar NULISA's 126 CNS panel proteins to evaluate internal correlations. Method We conducted a cross‐sectional analysis of plasma samples from 116 ARIC participants (part of the ARIC calibration panel). Biomarkers were quantified using the ALAMAR NULISA platform, measuring 126 CNS specific analytes. ATN & I biomarkers included: A (Aβ proteinopathy) – Aβ‐42, Aβ‐40, and Aβ‐42/40; T (phosphorylated and secreted AD tau) ‐ p ‐tau217, p ‐tau181, p ‐tau231 and their ratios with Aβ‐42; N (injury, dysfunction, or degeneration of neuropil) – NfL and Total Tau; and I (inflammation ‐ Astrocytic activation) – GFAP. Multiple linear regression was used to examine ATN & I biomarker associations with the 126 CNS NULISA proteins. Bonferroni correction was used to adjust for multiple comparisons. Analyses adjusted for age, sex, APOE ε4 status, education, and glomerular filtration rate (GFR). Spearman's Rho correlations were utilized to examine ATN & I protein associations amongst themselves. Result Of the 116 participants (age = 74.3 ± 4.7), 50% were female, and 88.8% were cognitively normal; 29.7% were APOE4 carriers. Aβ proteinopathy proteins showed moderate to strong correlations with each other (ρ = .52‐.88), mild to moderate correlations with phosphorylated and secreted AD tau markers (ρ = .20‐.68), and negative correlations with tau ratios with Aβ‐42 (‐.14 to ‐.55). The Aβ‐42/40 ratio showed mild correlations with other biomarkers. Among 126 Alamar proteins, 38 plasma proteins were associated with NfL, 37 with Aβ‐42 and Aβ‐40, and 35 with Tau. Top hits included IL‐33, MAPT, VEGFD, TAFA‐5, FOLR1, and GDB/1. Conclusion AD‐specific proteins are moderately to strongly correlated with each other on the Alamar platform. The most significantly associated proteins with ATN & I biomarkers within the platform included markers subserving inflammation, connective tissue integrity, and vascular function. Follow up studies should be longitudinal with individuals across the AD continuum.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2025-12-01
DOI
https://doi.org/10.1002/alz70856_106823
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Associations between classical Alzheimer's Disease biomarkers and key proteins defining potential pathophysiological mechanisms – A multi‐analyte proteomic analysis

Hubert Leo, Omonigho M. Bubu, Joshua L. Gills, The ARIC Neurocognitive Biomarker Workgroup
Alzheimer s & Dementia
Alzheimer's disease research and treatments
article

Associations between classical Alzheimer's Disease biomarkers and key proteins defining potential pathophysiological mechanisms – A multi‐analyte proteomic analysis

Hubert Leo, Omonigho M. Bubu, Joshua L. Gills, The ARIC Neurocognitive Biomarker Workgroup
article en

Abstract

Abstract Background Plasma biomarkers like amyloid‐beta Aβ42/Aβ40, p ‐tau isoforms, and NfL are promising for assessing AD risk and pathology. Emerging platforms such as Nucleic Acid‐Linked Immuno‐Sandwich Assay (NULISA) enable precise detection of low‐abundance proteins, offering insights into AD mechanisms. We examined associations between Alamar's NULISA proteins related to AD (amyloid, tau, neurodegeneration, and inflammation [ATN & I]) and Alamar NULISA's 126 CNS panel proteins to evaluate internal correlations. Method We conducted a cross‐sectional analysis of plasma samples from 116 ARIC participants (part of the ARIC calibration panel). Biomarkers were quantified using the ALAMAR NULISA platform, measuring 126 CNS specific analytes. ATN & I biomarkers included: A (Aβ proteinopathy) – Aβ‐42, Aβ‐40, and Aβ‐42/40; T (phosphorylated and secreted AD tau) ‐ p ‐tau217, p ‐tau181, p ‐tau231 and their ratios with Aβ‐42; N (injury, dysfunction, or degeneration of neuropil) – NfL and Total Tau; and I (inflammation ‐ Astrocytic activation) – GFAP. Multiple linear regression was used to examine ATN & I biomarker associations with the 126 CNS NULISA proteins. Bonferroni correction was used to adjust for multiple comparisons. Analyses adjusted for age, sex, APOE ε4 status, education, and glomerular filtration rate (GFR). Spearman's Rho correlations were utilized to examine ATN & I protein associations amongst themselves. Result Of the 116 participants (age = 74.3 ± 4.7), 50% were female, and 88.8% were cognitively normal; 29.7% were APOE4 carriers. Aβ proteinopathy proteins showed moderate to strong correlations with each other (ρ = .52‐.88), mild to moderate correlations with phosphorylated and secreted AD tau markers (ρ = .20‐.68), and negative correlations with tau ratios with Aβ‐42 (‐.14 to ‐.55). The Aβ‐42/40 ratio showed mild correlations with other biomarkers. Among 126 Alamar proteins, 38 plasma proteins were associated with NfL, 37 with Aβ‐42 and Aβ‐40, and 35 with Tau. Top hits included IL‐33, MAPT, VEGFD, TAFA‐5, FOLR1, and GDB/1. Conclusion AD‐specific proteins are moderately to strongly correlated with each other on the Alamar platform. The most significantly associated proteins with ATN & I biomarkers within the platform included markers subserving inflammation, connective tissue integrity, and vascular function. Follow up studies should be longitudinal with individuals across the AD continuum.

Alzheimer s & DementiaVol. 21(S2)
NYU Langone Health (US), New York University (US)
Openalex Percentile: Top 31%
Alzheimer's disease research and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.